| Anthem Blue Cross | Augmentative and Alternative Communication Devices with Digitized or Synthesized Speech Output | 2026-10-01 |
| Anthem Blue Cross | Spinal Hardware: Investigational | 2026-10-01 |
| Anthem Blue Cross | Topical Continuous Diffusion of Oxygen Therapy | 2026-10-01 |
| Anthem Blue Cross | Implantable Devices for Remote Monitoring of Heart Failure | 2026-10-01 |
| Anthem Blue Cross | Ankle-Foot and Knee-Ankle-Foot Orthoses | 2026-10-01 |
| Anthem Blue Cross | External Lower Extremity Sensory Prosthetic Devices | 2026-10-01 |
| UHC Surest Medical and Drug | Buprenorphine (Brixadi® & Sublocade®) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-10-01 |
| UHC Surest Medical and Drug | Denosumab – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-10-01 |
| UHC Surest Medical and Drug | Gamifant® (Emapalumab-Lzsg) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-10-01 |
| UHC Surest Medical and Drug | Long-Acting Injectable Antiretroviral Agents for HIV – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-10-01 |